CCL5 has been reported to trigger invasion by increasing the release of matrix metalloproteinases 2 and 9 in prostate cancer and cancer cell motility and invasion by being secreted by mesenchymal stem cells in the TME in breast cancer [26,27]. The gene discussed is CCL5; the disease is breast cancer.